Advanced Accelerator Applications SA (NASDAQ:AAAP)‘s stock had its “buy” rating reiterated by research analysts at Canaccord Genuity in a research report issued on Monday. They presently have a $47.00 price target on the stock. Canaccord Genuity’s price target indicates a potential upside of 38.60% from the stock’s previous close.

A number of other equities analysts have also commented on the stock. Wells Fargo & Co. started coverage on shares of Advanced Accelerator Applications SA in a report on Tuesday, October 18th. They issued an “outperform” rating on the stock. Zacks Investment Research raised shares of Advanced Accelerator Applications SA from a “hold” rating to a “buy” rating and set a $44.00 price target on the stock in a report on Tuesday, October 11th. Finally, Jefferies Group reissued a “buy” rating and issued a $45.00 price target on shares of Advanced Accelerator Applications SA in a report on Wednesday, October 12th. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Advanced Accelerator Applications SA has a consensus rating of “Buy” and an average target price of $39.67.

Analyst Recommendations for Advanced Accelerator Applications SA (NASDAQ:AAAP)

Shares of Advanced Accelerator Applications SA (NASDAQ:AAAP) traded down 8.58% on Monday, hitting $31.00. 181,705 shares of the stock traded hands. Advanced Accelerator Applications SA has a 52 week low of $20.53 and a 52 week high of $39.66. The stock has a 50 day moving average price of $37.04 and a 200-day moving average price of $33.41. The stock’s market cap is $1.22 billion.

WARNING: “Advanced Accelerator Applications SA (AAAP) Earns “Buy” Rating from Canaccord Genuity” was reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright law. The original version of this piece can be read at https://www.thecerbatgem.com/2016/11/28/advanced-accelerator-applications-sa-aaap-earns-buy-rating-from-canaccord-genuity.html.

Institutional investors have recently added to or reduced their stakes in the stock. Royce & Associates LP acquired a new position in Advanced Accelerator Applications SA during the second quarter valued at approximately $454,000. Alps Advisors Inc. raised its position in Advanced Accelerator Applications SA by 27.2% in the second quarter. Alps Advisors Inc. now owns 55,178 shares of the company’s stock valued at $1,668,000 after buying an additional 11,796 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of Advanced Accelerator Applications SA by 188.0% in the third quarter. Price T Rowe Associates Inc. MD now owns 1,450,739 shares of the company’s stock valued at $55,244,000 after buying an additional 947,069 shares during the last quarter. Baker BROS. Advisors LP purchased a new stake in shares of Advanced Accelerator Applications SA during the third quarter valued at $39,194,000. Finally, Scopia Capital Management LP purchased a new stake in shares of Advanced Accelerator Applications SA during the third quarter valued at $27,095,000. 20.76% of the stock is currently owned by institutional investors.

Advanced Accelerator Applications SA Company Profile

Advanced Accelerator Applications SA is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer.

5 Day Chart for NASDAQ:AAAP

Receive News & Stock Ratings for Advanced Accelerator Applications SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Accelerator Applications SA and related stocks with our FREE daily email newsletter.